Compare AORT & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AORT | QQQX |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1996 | N/A |
| Metric | AORT | QQQX |
|---|---|---|
| Price | $20.30 | $28.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $40.91 | N/A |
| AVG Volume (30 Days) | ★ 507.9K | 100.0K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.03% |
| EPS Growth | ★ 165.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $298,836,000.00 | N/A |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | $10.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.01 | N/A |
| 52 Week Low | $19.16 | $25.35 |
| 52 Week High | $48.25 | $31.87 |
| Indicator | AORT | QQQX |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 37.37 |
| Support Level | $19.73 | $28.54 |
| Resistance Level | $24.41 | $31.03 |
| Average True Range (ATR) | 1.29 | 0.55 |
| MACD | 0.07 | -0.19 |
| Stochastic Oscillator | 4.37 | 19.43 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets (as defined below) in a diversified equity portfolio made up of securities comprising the S&P 500 Index (or securities that have economic characteristics that are similar to those securities comprising the S&P 500 Index) that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund's option strategy.